Tech Company Financing Transactions
Durata Therapeutics Funding Round
On 3/31/2011, Durata Therapeutics secured $4.4 million in investment from Canaan Partners and Sofinnova Ventures.
Transaction Overview
Company Name
Announced On
3/31/2011
Transaction Type
Venture Equity
Amount
$4,396,000
Round
Undisclosed
Investors
Canaan Partners (Brent Ahrens)
Sofinnova Ventures (James Healy)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
200 South Wacker Dr. 2550
Chicago, IL 60606
USA
Chicago, IL 60606
USA
Phone
Website
Email Address
Overview
Durata Therapeutics is a clinical, development-stage pharmaceutical company focused on the treatment of infectious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Edick
Chief Medical Officer
Michael Dunne
Chief Operating Officer
Corey Fishman
Browse more venture capital transactions:
Prev: 3/31/2011: Scout Analytics venture capital transaction
Next: 3/31/2011: AppMetrics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs